Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Enovis CAO Oliver Engert buys $149,970 in company stock

Enovis CAO Oliver Engert buys $149,970 in company stock

Chief Administrative Officer Oliver Engert from Enovis (NASDAQ:ENOV) recently bought shares of his own company worth $149,970, as disclosed in a recent SEC Form 4 filing. This transaction occurred amidst the stock's current price of $18.56, which is slightly above its 52-week low of $18.52. The stock has plummeted by 25% over the past week. InvestingPro suggests the stock could be underpriced at its current valuation, with the firm's market cap standing at $1.12 billion.

On September 2, 2026, Engert acquired 2,458 shares at an average price of $20.32 per share. These shares were purchased in several transactions, with individual prices fluctuating between $20.145 and $20.50 per share. The next day, on September 3, 2026, Engert completed the purchase of an additional 5,140 shares, with a weighted average price of $19.46 per share, ranging from $19.33 to $19.75 per share. Subsequently, Engert now holds a total of 61,238 shares of Enovis common stock.

For a more in-depth analysis of Enovis's valuation and performance, InvestingPro offers an extensive ProTips package and a comprehensive Pro Research Report on the stock. In related news, Enovis Corporation reported second-quarter 2026 adjusted earnings of $0.90 per share, exceeding analysts' expectations of $0.85. The company's revenue for the quarter was $582.78 million, matching market forecasts.

Furthermore, Enovis announced the acquisition of French surgical robotics company eCential Robotics for around €176 million, or approximately $205 million. The acquisition's enterprise value is estimated at €155 million, with potential extra payments up to €35 million, contingent on meeting specific milestones.

Following the acquisition, some analysts have lowered their price targets for Enovis. Citizens decreased their price target from $55 to $47, while maintaining a Market Outperform rating. BMO Capital Markets also reduced their price target from $30 to $27, citing margin challenges arising from the deal. Enovis projects a 100 basis point margin headwind in 2027 due to this transaction. These developments highlight the company's strategic actions and the cautious perspective of analysts on the financial implications.

Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at investing.com →

More in Finance & Markets

Homebuyers in Thailand Face Soaring Mortgage Rejections

CHIANG RAI – Buying a house in Thailand used to depend heavily on proving your monthly income. Now, it takes a lot more to get the green light from financial institutions. Mortgage rejection rates have skyrocketed recently, hitting unprecedented highs across the entire country.

More from Saturday 5 September →